The purpose of the Indiana Tuberculosis Prevention & Care Program is to progress toward elimination of TB by conducting prevention activities through education, outreach, collaboration, and surveillance.
Available via Purdue Pharmacy as of April 9, 2026: Rifampin (4R) and Isoniazid, Rifampin (3HR), and Rifapentine (3HP)
Alternate: Isoniazid (6H/9H)
Medication Update - Rifabutin is currently on a manufacturer backorder.
Local Health Departments and Public Health Nurses should confer with their regional nurse consultants when deciding on prescription options.
TB Tips for Infection Preventionists (pdf)
Heartland TB Center Isolation Guidance (pdf)
Discharge Planning Checklist (pdf) - This is a sample, and there is no requirement to use this template. Please follow applicable local policies and procedures.
Contact Investigation Templates
Indiana APIC Conference Poster TB & Infection Prevention Resources (pdf)
TB Reportable Condition Reporting Guidance
LTBI Reportable Condition Reporting Guidance
TB/LTBI NBS Quick Guides & Workflows
Cuba, Haiti, Nicaragua, and Venezuela Arrival Fact Sheet for LHDs (pdf)
Dept. of Health & Human Services Guidance for Providers Caring for Newcomers Arriving from Cuba, Haiti, Nicaragua, and Venezuela (pdf)
| Parolee Programs & Health Screenings | ||||
|---|---|---|---|---|
| Program | Parolee Receives Overseas Medical Screening | IGRA (TB Blood Test) within 90 Days of Arrival in United States Required | Parolee is Eligible for Domestic Refugee Health Screening | Data Captured in Electronic Disease Notification (EDN) |
| Uniting for Ukraine Paroled into the United States between February 24, 2022 - September 30, 2023+ | No | Yes | Yes | No |
| Cuba, Haiti, Nicaragua, Venezuela (CHNV) | No | Yes | Yes* | No |
| Columbia, El Salvador, Guatemala, Honduras Family Reunification Parole Program (CEGH) | Yes | No | No | Yes |
+ Relatives of ORR-eligible Ukrainian parolees are eligible for ORR refugee benefits and services, even if they are paroled into the United States after September 30, 2023. * Cuban and Haitian parolees under this program are eligible for a refugee health screening. Currently, Nicaraguan and Venezuelan parolees under this program are not eligible. Note: These screenings are separate from traditional Class B designations. | ||||
World TB Day Summit 2026
TB Prevention & Care Program Updates for LHDs 12-14-23 (pdf) and recording link
IDOH Lab Webcast TB presentation 12-13-23 (pdf)
TB-Refugee Health New LHD PHN Program Orientation 12-7-23 (pdf)
What a LHD Administrator Should Know About TB (pdf)
What Happens After a Positive TST or IGRA (pdf)
TB Update (pdf)
TB Prevention & Case Management: Core Services & Isolation Updates (pdf)
Page last reviewed/updated: April 2026
